Literature DB >> 29417040

Diagnostic criteria for drug rash and eosinophilia with systemic symptoms.

Ashok Kumar Pannu1, Atul Saroch2.   

Abstract

Entities:  

Year:  2017        PMID: 29417040      PMCID: PMC5787987          DOI: 10.4103/2249-4863.222050

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


× No keyword cloud information.
Dear Editor, We found the paper by Jmeian et al. concerning a case of allopurinol-related drug rash with eosinophilia and systemic symptoms (DRESS) in a patient of chronic kidney disease and gout, interesting.[1] The presence of eosinophilia, the temporal relationship of the symptoms with the initiation of treatment with allopurinol, and the marked improvement on withdrawal of the drug along with the administration of systemic corticosteroids were features suggesting the diagnosis of DRESS. DRESS is considered a severe drug reaction with a case fatality rate of 10–20%.[2] The diagnosis is sometimes difficult since the clinical manifestations may be incomplete or nonspecific, and it can also present as a purely systemic disease without any cutaneous involvement.[34] Multiple diagnostic criteria have been developed and used to standardize the diagnosis and management of DRESS, albeit with limited success. Bocquet et al. were the first who proposed criteria for DRESS [Table 1].[5] The Registry of Severe Cutaneous Adverse Reaction (RegiSCAR) group suggested criteria for hospitalized patients with a drug rash to diagnose DRESS syndrome [Table 2].[6] RegiSCAR constitutes a European RegiSCAR, including Stevens–Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and DRESS. In an effort to define more accurately the DRESS syndrome, a scoring system has also been developed the RegiSCAR scoring system [Table 3].[6] A Japanese group suggested another set of diagnostic criteria; however, universal adaptation of this criteria may be limited since one of the criteria includes HHV-6 activation and some tests, such as measurement of IgG titer anti-HHV 6, are yet not routinely available [Table 4].[7]
Table 1

Bocquet et al. proposed criteria for diagnosis of drug rash and eosinophilia with systemic symptoms/drug-induced hypersensitivity

Table 2

Registry of severe cutaneous adverse reaction criteria for diagnosis of drug rash and eosinophilia with systemic symptoms

Table 3

Registry of severe cutaneous adverse reaction diagnosis score for drug rash and eosinophilia with systemic symptoms

Table 4

Japanese group's criteria for diagnosis of drug rash and eosinophilia with systemic symptoms/drug-induced hypersensitivity

Bocquet et al. proposed criteria for diagnosis of drug rash and eosinophilia with systemic symptoms/drug-induced hypersensitivity Registry of severe cutaneous adverse reaction criteria for diagnosis of drug rash and eosinophilia with systemic symptoms Registry of severe cutaneous adverse reaction diagnosis score for drug rash and eosinophilia with systemic symptoms Japanese group's criteria for diagnosis of drug rash and eosinophilia with systemic symptoms/drug-induced hypersensitivity DRESS is a challenging drug adverse reaction which can cause life-threatening organ dysfunction. Clinicians must be alert to this possibility to reach the correct diagnosis and institute the appropriate management.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  7 in total

1.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

2.  The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations.

Authors:  T Shiohara; M Iijima; Z Ikezawa; K Hashimoto
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

Review 3.  Drug hypersensitivity syndrome.

Authors:  Rashmi Kumari; Dependra K Timshina; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Jan-Feb       Impact factor: 2.545

Review 4.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

5.  Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients.

Authors:  Mona Ben M'rad; Stéphanie Leclerc-Mercier; Philippe Blanche; Nathalie Franck; Flore Rozenberg; Yvonne Fulla; Myriam Guesmi; Florence Rollot; Monique Dehoux; Loïc Guillevin; Laurence Moachon
Journal:  Medicine (Baltimore)       Date:  2009-05       Impact factor: 1.889

6.  Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.

Authors:  Sarita Sasidharanpillai; Najeeba Riyaz; Uma Rajan; Manikoth P Binitha; Anza Khader; Olasseri K Reena Mariyath; Rajiv John; Jayasree Puravoor
Journal:  Indian J Dermatol Venereol Leprol       Date:  2014 May-Jun       Impact factor: 2.545

7.  Skin rash, eosinophilia, and renal impairment in a patient recently started on allopurinol.

Authors:  Ashraf Jmeian; Amer Hawatmeh; Razan Shamoon; Fayez Shamoon; Michael Guma
Journal:  J Family Med Prim Care       Date:  2016 Apr-Jun
  7 in total
  2 in total

1.  Atypical Manifestation of DRESS Syndrome.

Authors:  Christopher Hakim; Constantine Melitas; Eric Nguyen; Kha Ngo
Journal:  Case Rep Gastrointest Med       Date:  2020-04-12

2.  DRESS syndrome due to first-line antitubercular therapy - A diagnostic imbroglio!

Authors:  Pratap K Patra; Aaqib Z Banday; Ankur K Jindal; Dharmagat Bhattarai; Nilamani Patra; Uma N Saikia; Anju Gupta; Deepti Suri
Journal:  J Family Med Prim Care       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.